Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 20

    CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

    CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

    Medical Dialogues Bureau22 Sept 2019 11:30 AM IST
    New Delhi: Through a recent notification, the Central Drugs Standard Control Organisation(CDSCO) has directed all the manufacturers of Fixed-Dose...
    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Farhat Nasim21 Sept 2019 3:21 PM IST
    The Sub-Committee is of the opinion that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for...
    No cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGI

    No cancer causing impurities found in BP drug Valsartan during initial approval process, says DCGI

    Medical Dialogues Bureau20 Sept 2019 4:02 PM IST
    V G Somani said, according to the information he had the impurities were not found during the initial approval process of the product (Valsartan)....
    Police protection for Drug Regulators, Inspectors, recommends CDSCO committee

    Police protection for Drug Regulators, Inspectors, recommends CDSCO committee

    Farhat Nasim19 Sept 2019 3:17 PM IST
    New Delhi: Taking cognizance of the grave concern of providing security and protection to Drug inspectors from threats, the Drugs Consultative...
    Apollo to separate out its pharmacy business, seeks shareholders nod

    Apollo to separate out its pharmacy business, seeks shareholders nod

    Farhat Nasim18 Sept 2019 5:37 PM IST
    New Delhi: Based on the directions of National Company Law Tribunal (NCLT), Apollo Hospitals Enterprise Ltd (AHEL) has proposed to hive off its...
    Glenmark bags USFDA orphan drug status for antibody GBR 1342 to treat multiple myeloma

    Glenmark bags USFDA orphan drug status for antibody GBR 1342 to treat multiple myeloma

    Medical Dialogues Bureau17 Sept 2019 4:14 PM IST
    Derived from the company's proprietary BEAT (Bispecific Engagement by Antibodies based on the T cell receptor) technology, GBR 1342 is being...
    Diabetes Management: Sanofi, Abbott team up to integrate glucose sensing, insulin delivery technologies

    Diabetes Management: Sanofi, Abbott team up to integrate glucose sensing, insulin delivery technologies

    Farhat Nasim16 Sept 2019 9:30 AM IST
    Sanofi and Abbott will take an approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with insulin...
    CDSCO apprises about the Continuity in validity of Written Confirmation Certificate for API consignments for Exports

    CDSCO apprises about the Continuity in validity of Written Confirmation Certificate for API consignments for Exports

    Farhat Nasim15 Sept 2019 10:36 AM IST
    New Delhi: Through a recent circular, the Central Drugs Standard Control Organisation (CDSCO) has apprised about maintaining the continuity in the...
    One Drug, Multiple Manufacturing Facilities: CDSCO approves manufacturing of new drug in additional sites

    One Drug, Multiple Manufacturing Facilities: CDSCO approves manufacturing of new drug in additional sites

    Farhat Nasim14 Sept 2019 4:38 PM IST
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has apprised drug makers that they can manufacture a new...
    Biocon inks license, supply pact with CMS for 3 generic formulations

    Biocon inks license, supply pact with CMS for 3 generic formulations

    Medical Dialogues Bureau13 Sept 2019 2:45 PM IST
    Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
    Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

    Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

    Medical Dialogues Bureau12 Sept 2019 5:41 PM IST
    The Ankleshwar site is Sanofi India's oldest manufacturing facility where brands like Combiflam, Allegra and Amaryl are made. The production of these...
    Cutting Debts: Apollo Hospitals sells stake worth Rs 720 crore

    Cutting Debts: Apollo Hospitals sells stake worth Rs 720 crore

    Farhat Nasim12 Sept 2019 5:03 PM IST
    Apollo promoters' are being guided by the Citigroup and HDFC Bank on the current stake sale. The 5 million shares or 3.6% stake in the company will be...
    PrevNext

    Popular Stories

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok